Condition: Respiratory Failure · ICU · Asthma (Diagnosis) · Sponsor: Hong Kong University
This is an observational study performed by retrospective review of data routinely collected for patients receiving low-flow extracorporeal carbon dioxide removal (ECCO2R) therapy in intensive care units (ICUs). Our aim is to firstly, describe the local practice in terms of patient selection and technical details of clinical management related to the use of low-flow ECCO2R system, and secondly, the clinical results in terms of patient outcomes and adverse events. These findings may allow clinicians to improve the quality and safety of ECCO2R therapy provision in the ICU.
This description comes directly from the study's public registry record.
Wai Ching Simon Sin, Director, Clinical Professor · (852)9090-8772 · drwcsin@hku.hk
SI CHEN, Master · (852)54630558 · cyn08ccs@hku.hk
Always discuss trial participation with your own doctor first.
| Queen Mary Hospital (QMH) | Hong Kong, Hong Kong | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07161271